[2] |
杨博洋,张杰.IL-37 与类风湿性节炎的研究进展[J].新疆中医药,2019,37(2):175-177.
|
[1] |
Eleanor D,John E,Martin J.Annotating genes with potential roles in the immune system:six new members of the IL-1 family[J].Trends Immunol,2001,22(10):533-536.
|
[3] |
Shuai X,Weimin L,Tong Y,et al.Expression of IL-37 contributes to the immunosuppressive property of human CD4+,CD25+regulatory T cells[J].Sci Rep,2015,5:14478.
|
[4] |
Fonseca G,Furuzawa J,Yamamo JK.Interleukin 35(IL-35)and IL-37:intestinal and peripheral expression by T and B regulatory cells in patients with inflammatory bowel disease[J].Cytokine,2015,75(2):389-402.
|
[5] |
马骥,李建春.结直肠癌患者血清IL-37 水平及与临床病理特征的关系[J].中国现代医学杂志,2020,30(24):30-34.
|
[6] |
费晓莉,陶黎,熊梅,等.IL-37、VEGF、LDH 和β_2-MG 在多发性骨髓瘤中的表达及其临床意义[J].重庆医学,2021,50(2):275-279.
|
[7] |
施武媚,吴剑兰,熊超.上皮性卵巢癌患者血清IL-37 变化与免疫抑制相关因子关联分析[J].中华肿瘤防治杂志,2020,27(21):1737-1741.
|
[8] |
Li P,Guo H,Wu K,et al.Decreased IL-37expression in hepatocellula carcinoma tis sues and liver cancer cell lines[J].Oncol Lett,2020,19(4):2639-2648.
|
[9] |
刘明娅,戚菲菲,鲍琳琳.白细胞介素-37 在流感病毒感染导致的重症肺炎中作用的研究进展[J].中国实验动物学报,2021,29(1):99-103.
|
[10] |
胡小超,邓存良.IL-37 抗肝纤维化作用研究进展[J].西南军医,2015,(1):65-67.
|
[11] |
李梦媛,杨星九,徐大模,等.IL-37 对炎症相关性疾病的抑制作用[J].中国比较医学杂志,2015,(12):75-80.
|
[12] |
张燕,熊霞.IL-37 及其与疾病相关性的研究进展[J].基础医学与临床,2015,35(4):549-553.
|
[13] |
陈诗皓,杜晓楠,李艳,等.IL-37 对粉尘螨诱导气道上皮及固有免疫细胞产生IL-6 的作用研究[J].微生物学免疫学进展,2017,45(4):1-7.
|
[14] |
彭慧慧,冷建杭,沈俊娅,等.Th17/Treg 和Th1/Th2 细胞失衡对变应性鼻炎发病机制的研究[J].中国卫生检验杂志,2020,30(18):2234-2237.
|
[15] |
Li Y,Zhao M,Guo C,et al.Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation[J].Oncogene,2018,37(8):1095-1106.
|
[16] |
Slattery ML,Mullany LE,Sakoda L,et al.The NF-κB signalling pathway in colorectal cancer:associations between dysregulated gene and miRNA expression [J].J Cancer Res Clin Oncol,2018,144(2):269-283.
|
[17] |
姜文佳,汤晓庆,汤国军,等.白细胞介素-37 在结直肠癌患者中的表达及其与基质金属蛋白酶-8、基质金属蛋白酶-9、血管内皮生长因子及可溶性细胞间黏附分子间的关 系[J].中国 卫 生检验杂 志,2019,29(14):1728-1731.
|
[18] |
Yan XF,Zhao J,Zhang R.Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression[J].Oncotarget,2017,8(30):49064-49075.
|
[19] |
Yu B,Wang J,He C,et al.Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer[J].Exp Ther Med,2017,14(1):831-840.
|
[20] |
Tong YS,Juan T,Xi LZ,et al.Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage Ⅲnon-small cell lung cancer[J].J Tranl Med,2017,15(1):221.
|
[21] |
Guanqun G,Aiqin W,Jingyue Y,et al.Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer[J].J Exp Clin Cancer Res,2016,35(1):13.
|
[22] |
Li ZC,Sun MD,Zheng YQ,et al.The Low Expression of IL-37 Involved in Multiple Myeloma Associated Angiogenesis[J].Med Sci Monit,2016,3(22):4164-4168.
|
[23] |
Yu M,Ying Z,Huey YT,et al.The indirect antiangiogenic effect of IL-37 in the tumor microenvironment[J].J Leukoc Biol,2020,107(5):783-796.
|
[24] |
费晓莉,陶黎,熊梅,等.IL-37、VEGF、LDH 和β_2-MG在多发性骨髓瘤中的表达及其临床意义[J].重庆医学,2021,50(2):275-279.
|
[25] |
蒋娟,邹勇德,蒋福平,等.IL-37 对宫颈癌HeLa 细胞增殖和凋亡的影响[J].肿瘤药学,2014,4(4):263-266.
|
[26] |
邓子亮,王森,黎鹏,等.白细胞介素37 对宫颈癌HeLa细胞顺铂化疗敏感性的增强作用[J].吉林大学学报(医学版),2017,43(5):862-866.
|
[27] |
曹海秀.经阴道彩色多普勒超声联合血清IL-37 和SCCA 诊断宫颈癌的临床应用价值[J].当代医学,2021,27(8):14-17.
|
[28] |
Mahmoud EH,Fawzy A,A Elshimy RA.Serum MicroRNA-21 Negatively Relates to Expression of Programmed Cell Death-4 in Patients with Epithelial Ovarian Cancer[J].Asian Pac J Cancer Prev,2018,19(1):33-38.
|
[29] |
施武媚,吴剑兰,熊超.上皮性卵巢癌患者血清IL-37 变化与免疫抑制相关因子关联分析[J].中华肿瘤防治杂志,2020,27(21):1737-1741.
|